XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Narrative (Details)
1 Months Ended 3 Months Ended
Mar. 01, 2022
USD ($)
Sep. 30, 2021
USD ($)
shares
Mar. 31, 2022
USD ($)
period
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2011
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options granted (in shares)     0    
Weighted-average grant date fair value, options granted (in dollars per share) | $ / shares       $ 2.69  
Aggregate grant-date fair value, options | $     $ 2,900,000 $ 1,400,000  
Intrinsic value of options exercised | $     12,606,000 2,600,000  
Tax benefit, stock-based compensation expense | $     0 0  
Tax benefit, exercise of stock-based awards | $     $ 0 $ 0  
Equity Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized         43,899,677
2021 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized   25,000,000      
Number of additional shares authorized   552,736      
Common stock, reserved (in shares)   25,552,736      
Common stock reserved for issuance, annual increase percentage   5.00%      
Stock options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock, reserved (in shares)     29,925,304    
Cliff vesting period     1 year    
Exercisable period     10 years    
Exercisable period, termination of service     3 months    
Stock options | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     2 years    
Stock options | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Performance sares          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period     4 years    
Cliff vesting period     1 year    
Share-based compensation expense, accelerated cost | $   $ 1,100,000      
Restricted stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted-average grant date fair value, granted (in dollars per share) | $ / shares     $ 13.06 $ 4.95  
Number of shares issued     124,026    
Granted (in shares)     2,480,410 0  
Weighted-average aggregate grant date fair value, vested | $     $ 500,000    
Vested (in shares)     81,060 0  
Unamortized compensation cost | $     $ 141,300,000    
Unamortized compensation cost, recognition period     3 years 2 months 12 days    
ESPP          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of purchase periods | period     4    
Purchase period     6 months    
Consecutive offering period     24 months    
Plan modification, incremental cost | $ $ 3,600,000        
Maximum employee contribution rate     15.00%    
ESPP purchase price of common stock, percent of market price     85.00%    
Unamortized compensation cost | $     $ 6,500,000    
Unamortized compensation cost, recognition period     1 year 10 months 24 days    
ESPP | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Consecutive offering period     27 months    
ESPP | ESPP          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares authorized   3,500,000      
Common stock, reserved (in shares)     4,940,182    
Common stock reserved for issuance, annual increase percentage   1.00%      
Maximum number of shares available over award term   35,000,000